Clinical Trials Browser

Phase 3 × Diphenhydramine × Plasma cell × Clear all

NCT04270409 2025-12-12

Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma

Phase 3 Active not recruiting

Multiple Myeloma